Concepedia

Publication | Closed Access

Serum CXCL16 as a Novel Biomarker of Coronary Artery Disease in Type 2 Diabetes Mellitus: a Pilot Study.

19

Citations

0

References

2016

Year

Fang Zhou, Jinxiang Wang, Ke Wang, Xiangqing Zhu, Rongqing Pang, Xuemei Li, Guangxu Zhu, Xinghua Pan
PubMed

Abstract

Serum CXCL16 may be a novel biomarker for the diagnosis of patients with T2DM-CAD.